Oncology On The Go

CancerNetwork•www.cancernetwork.com

{"_":"Oncology On The Go is a weekly podcast that talks to authors and experts to thoroughly examine featured articles in the journal ONCOLOGY and review other challenging treatment scenarios in the cancer field from a multidisciplinary perspective. Our discussions also offer timely insight into topics ranging from recent FDA approvals to relevant research presented at major oncology conferences.
\n
\nAs the home of the journal ONCOLOGY, CancerNetwork offers different perspectives on oncology/hematology through review articles, news, podcasts, blogs, and more.
\n
\nTo learn more, you can also visit us on Facebook, Twitter, and LinkedIn!\n","$":{"audioboom:html":"1"}}

Last refreshed: June 22nd, 2026 at 12:30 PM ⓘ

Follow this podcast in the Metacast mobile app to refresh it and see new episodes.

Follow on

Apple Podcasts

Spotify

RSS

Podcasts are better in Metacast mobile app

Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more

Episodes

S1 Ep6: 1-on-1 with Dr. Michael Randell: New ACS Guidelines for Cervical Cancer

CancerNetwork speaks with Michael Randell, MD, FACOG, of OBGYN Atlanta to learn more about the new cervical cancer screening guidelines released by the American Cancer Society. In the interview, Randell expresses his concerns with the updated guidelines, and details what he recommends to patients. Don’t forget to subscribe to the Oncology Peer Review On-The-Go podcast on Apple Podcasts, Spotify or anywhere podcasts are available.

Sep 14, 2020•9 min•Season 1Ep. 6

S1 Ep5: Is Next-Generation Sequencing a Right for Patients with GI Cancers?

In the latest episode of "Oncology Peer Review On-The-Go," CancerNetwork examines a Q&A piece in the August issue of the journal ONCOLOGY discussing next-generation sequencing for gastrointestinal cancers. The article is titled “Ushering in the Era of Precision Medicine” and it focuses on a conversation with Tanios Bekaii-Saab, MD, of the Mayo Clinic in Phoenix, Arizona. For a responding perspective, CancerNetwork spoke with Howard Hochster, MD, of the Rutgers Cancer Institute of New Jersey....

Aug 31, 2020•33 min•Season 1Ep. 5

S1 Ep4: The COVID-19 Pandemic's Impact on Cancer Screenings

In this week’s episode, CancerNetwork speaks with Christopher McNair, PhD, of the Sidney Kimmel Cancer Center – Jefferson Health for an in-depth discussion on how the COVID-19 pandemic has impacted cancer screenings. Then, CancerNetwork speaks with Lisa Berry Edwards, managing director of external affairs for the PreventCancer Foundation, to talk about their “Back on the Books” initiative working to get cancer screenings and regular appointments rescheduled during the pandemic. Don’t forget to s...

Aug 17, 2020•21 min•Season 1Ep. 4

S1 Ep3: Clinical Trials System and the COVID-19 Pandemic

On this week's episode of Oncology Peer Review On-The-Go, CancerNetwork examines an article from the July issue of the journal ONCOLOGY entitled “Oncology Clinical Trials During the COVID-19 Pandemic.” The article was written by Aline Lara, MD, Denis Jardim, MD, PhD, and Diogo Bastos, MD. CancerNetwork spoke with Dr. Lara and Dr. Bastos for an overview of the review article. Then, CancerNetwork speaks with Mehmet Copur, MD, of the Morrison Cancer Center for a peer reviewed perspective. Dr. Copur...

Aug 03, 2020•26 min•Season 1Ep. 3

S1 Ep2: 1-on-1 with Dr. Xu Ji: Mental Health Among Cancer Survivors

In this episode of Oncology Peer Review On-The-Go, CancerNetwork speaks 1-on-1 with Xu Ji, PhD, MSPH, of the Winship Cancer Institute regarding her research entitled "Mental Health Among Nonelderly Adult Cancer Survivors: A National Estimate."

Jul 20, 2020•14 min•Season 1Ep. 2

S1 Ep1: Minority Treatment Disparities and Clinical Trial Enrollment

CancerNetwork talks with Christopher Flowers, MD, of the MD Anderson Cancer Center regarding "Strategies for Overcoming Disparities for Patients With Hematologic Malignancies and for Improving Enrollment on Clinical Trials" from the journal ONCOLOGY. Then, Julie Vose, MD, of the University of Nebraska Medical Center gives her perspective on the factors leading to cancer care disparities and the significance of representative enrollment in clinical trials.

Jul 06, 2020•18 min•Season 1Ep. 1

← Prev

For the best experience, listen in Metacast app for iOS or Android